Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
02 Jun, 2026, 09.53 AM IST
Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
29 May, 2026, 08.46 PM IST
Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
27 May, 2026, 12.24 PM IST
The ugliest animal on Earth may be humanity's best hope for living longer — here's the scienceNaked mole rats, known for their longevity and cancer resistance, possess high levels of a protective molecule called HMW-HA. Researchers s...
12 May, 2026, 05.32 AM IST
Scientists just found the holy grail gene that could let humans regrow their own limbs one dayScientists studying naked mole rats discovered a gene linked to high levels of high molecular weight hyaluronic acid (HMW-HA), a substance ...
11 May, 2026, 11.52 PM IST
What is shelf-stable synthetic blood? The scientific advancement that could transform battlefield and emergency careA revolutionary synthetic blood is nearing human trials. This freeze-dried product can be stored for years at room temperature. It can be r...
23 Apr, 2026, 12.43 PM IST
How Russian cancer vaccines EnteroMix and personalized mRNA work to control the life-threatening diseaseRussia's cancer vaccine, comprising EnteroMix and personalized mRNA vaccines, has completed preclinical trials, showcasing safety and high ...
08 Sep, 2025, 01.48 PM IST
Russian vaccine for colon cancer ready to use: ReportRussia's Federal Medical Biological Agency (FMBA) has announced the successful completion of preclinical trials for its cancer vaccine, dem...
07 Sep, 2025, 06.21 PM IST
Favipiravir drug shows promise against Chandipura virus in preclinical studies by NIVFavipiravir offers hope against the Chandipura virus. Studies by the National Institute of Virology show promising results. The drug reduce...
24 Jun, 2025, 03.27 PM IST
Bharat Biotech shares elaborate data of all research studies of CovaxinCovaxin, a whole-virion inactivated coronavirus vaccine, is the first and only product to have published any data from human clinical trial...
14 Jun, 2021, 10.22 AM IST
'Excellent safety' of 2 indigenous COVID candidate vaccines revealed during Phase-I trials: MinisterSerum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates.
15 Sep, 2020, 05.27 PM IST
Bharat Biotech’s Chikungunya vaccine enters phase-1 clinical trialsIn a statement, the company said “the placebo controlled study involving 60 healthy volunteers would test escalating doses of the vaccine i...
05 Jun, 2017, 12.10 PM IST
Glenmark Pharmaceuticals's monoclonal antibody for pain entering human trialsGBR 900 is a monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of nerve growth factor (NGF).
29 Apr, 2014, 04.57 PM IST
- Zydus files IND application with DCGI for diabetes and obesity
Healthcare major, Zydus Cadila has filed IND (Investigational New Drug) application for anti-diabetic and anti-obesity drug with Drugs Cont...
04 Jun, 2009, 03.53 PM IST
- Ranbaxy closes second out-licensing deal
Ranbaxy Laboratories’ research programme moved up by a step. Its novel statin is the second compound from the company’s new drug discovery ...
02 Mar, 2007, 12.54 AM IST
- Ranbaxy's cholesterol lowering drug acquired by PPD
Ranbaxy Laboratories on Tuesday said US-based contact research organisation PPD Inc has acquired exclusive worldwide license to develop, ma...
01 Mar, 2007, 03.00 PM IST
- Glenmark's asthma molecule trials crawl on
Glenmark Pharmaceuticals’ much-hyped asthma research molecule Oglemilast (code name GRRC 3886), is witnessing slower clinical progress, put...
20 Oct, 2006, 12.43 AM IST